发明名称 METABOLIC INTERVENTION WITH GLP-1 OR ITS BIOLOGICALLY ACTIVE ANALOGUES TO IMPROVE THE FUNCTION OF THE ISCHEMIC AND REPERFUSED BRAIN
摘要 It has now been discovered that GLP-1 treatment after acute stroke or hemorrhage, preferably intravenous administration, can be an ideal treatment because it provides a means for optimizing insulin secretion, increasing brain anabolism, enhancing insulin effectiveness by suppressing glucagon, and maintaining euglycemia or mild hypoglycemia with no risk of severe hypoglycemia.
申请公布号 WO0066142(A3) 申请公布日期 2002.01.24
申请号 WO2000US11652 申请日期 2000.05.01
申请人 BIONEBRASKA, INC. 发明人 COOLIDGE, THOMAS, R.;EHLERS, MARIO, R., W.
分类号 A61K45/00;A61K31/7004;A61K38/00;A61K38/26;A61P9/10;(IPC1-7):A61K38/26 主分类号 A61K45/00
代理机构 代理人
主权项
地址